Atlas Trials

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Clinical trial NCT04545788 · UNKNOWN

Trial details

NCT number
NCT04545788
Sponsor
Beijing Chest Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Tuberculosis
Start date
2020-08-01
Primary completion
2022-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.